Incubate launches "Small Molecules, Big Voices" series to highlight the value of small molecule drugs
September 09, 2024 15:49 ET
|
Incubate
Washington, DC, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Today, Incubate launched the "Small Molecules, Big Voices" video series to illustrate the importance of small molecule drugs to patients,...
Incubate responds to Maximum Fair Prices for first 10 drugs selected for Medicare price controls
August 15, 2024 14:04 ET
|
Incubate
Washington, DC, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Today, the Biden administration announced Maximum Fair Prices (MFPs) for the first 10 drugs selected for Medicare price setting under the Inflation...
Incubate launches advertising campaign across North Carolina
May 01, 2024 09:59 ET
|
Incubate
Washington, DC, May 01, 2024 (GLOBE NEWSWIRE) -- Today, Incubate launched a six-figure advertising campaign across North Carolina commending Representatives Greg Murphy (R-NC) and Don Davis (D-NC)...
Incubate Launches Policy Lab Under New Leadership and Releases IP White Paper
April 26, 2024 09:30 ET
|
Incubate
Washington, DC, April 26, 2024 (GLOBE NEWSWIRE) -- Today, on World Intellectual Property Day, Incubate is excited to launch Incubate Policy Lab under the guidance of senior advisor Kirsten Axelsen....
Incubate Coalition: Life sciences investors react to first 10 drugs selected for government price controls
August 29, 2023 08:44 ET
|
Incubate
Washington, DC, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Today, the Centers for Medicare & Medicaid Services announced the first 10 Medicare Part D drugs selected for government price setting under the...
Report from Incubate Policy Lab and Charles River Associates Finds Price Controls Would Decrease Investment in Critical Therapeutic Areas
November 18, 2021 17:08 ET
|
Incubate
Washington, D.C., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Today, Incubate Policy Lab and Charles River Associates published a report detailing how investment into therapies for rare diseases and oncology...
Report from Incubate Policy Lab and Charles River Associates Finds Congressional Budget Office Underestimates Negative Impact of Drug Pricing Legislation
October 20, 2021 10:09 ET
|
Incubate
Washington, D.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Today, Incubate Policy Lab and Charles River Associates published a report demonstrating that a leading proposal that would allow the federal...
Life Sciences Investors Sound the Alarm Over Drug Price Negotiations at Incubate Panel
September 16, 2021 12:35 ET
|
Incubate
Washington, D.C., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Yesterday, a group of early-stage life science investors and biotech CEOs joined together with a prominent patient advocate to speak out against...
Biotech Investors Warn Against Innovation-Killing Policies at Expert Panel
December 18, 2020 15:22 ET
|
Incubate
Washington, D.C., Dec. 18, 2020 (GLOBE NEWSWIRE) -- The federal government may soon kneecap the life sciences industry, prominent biotech investors warned Thursday during a panel discussion...
INCUBATE RAISES CONCERN ABUT PRESIDENT TRUMP'S EXECUTIVE ORDER ON DRUG PRICING
July 31, 2020 17:10 ET
|
Incubate
Washington, DC, July 31, 2020 (GLOBE NEWSWIRE) -- Last week, President Trump signed four Executive Orders (EO) to lower prescription drug costs. One Executive Order was discussed that would import...